Oramed Pharmaceuticals, Inc. (ORMP)
3.42
+0.03
(+0.88%)
USD |
NASDAQ |
Apr 02, 16:00
3.42
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Shareholders Equity (Quarterly) : 199.74M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lifeward Ltd. | 8.408M |
| Bristol Myers Squibb Co. | 18.47B |
| Merck & Co., Inc. | 52.61B |
| Instil Bio, Inc. | 113.87M |
| Moderna, Inc. | 8.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 230.86M |
| Total Liabilities (Quarterly) | 31.12M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 6.983 |
| Net Debt Paydown Yield | -0.07% |